- Capricor Therapeutics EVP, General Counsel Karen Krasney sold 25,000 shares on March 31, 2026 at weighted average price of $30.12.
- Krasney exercised stock options for 24,000 shares on March 31, 2026 at prices ranging from $1.39 to $3.74.
- Directly held common stock position fell to 30,547 shares following reported transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capricor Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001593086-26-000006), on April 01, 2026, and is solely responsible for the information contained therein.
Comments